Beiyang Wei

1.3k total citations
19 papers, 1.1k citations indexed

About

Beiyang Wei is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Beiyang Wei has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Beiyang Wei's work include Protease and Inhibitor Mechanisms (13 papers), Peptidase Inhibition and Analysis (6 papers) and Cell Adhesion Molecules Research (6 papers). Beiyang Wei is often cited by papers focused on Protease and Inhibitor Mechanisms (13 papers), Peptidase Inhibition and Analysis (6 papers) and Cell Adhesion Molecules Research (6 papers). Beiyang Wei collaborates with scholars based in United States, South Korea and Japan. Beiyang Wei's co-authors include William G. Stetler‐Stevenson, Dong Wan Seo, Hongmei Li, Liliana Guédez, Paul T. Wingfield, Dimitra Bourboulia, Junseo Oh, Sandra Jensen-Taubman, Young Sik Kim and Young S. Hahn and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Beiyang Wei

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beiyang Wei United States	13	522	519	334	169	164	19	1.1k
Rajeev Mahimkar United States	15	463 0.9×	372 0.7×	323 1.0×	136 0.8×	88 0.5×	18	1.1k
Ida Katrine Lund Denmark	18	335 0.6×	356 0.7×	264 0.8×	117 0.7×	132 0.8×	43	839
Ralf‐Peter Czekay United States	15	582 1.1×	747 1.4×	275 0.8×	318 1.9×	169 1.0×	18	1.5k
Kai Doberstein Germany	19	524 1.0×	249 0.5×	299 0.9×	83 0.5×	182 1.1×	27	1.1k
Fazilat F. Mohammed Canada	8	317 0.6×	361 0.7×	284 0.9×	102 0.6×	121 0.7×	9	1.0k
Stephanie Lefèvre Germany	10	453 0.9×	179 0.3×	238 0.7×	114 0.7×	292 1.8×	11	1.2k
Adelheid Korb Germany	8	950 1.8×	198 0.4×	482 1.4×	114 0.7×	491 3.0×	9	2.0k
Irene A. Rigault de la Longrais Italy	20	799 1.5×	435 0.8×	345 1.0×	47 0.3×	64 0.4×	26	1.4k
Behrouz Zand United States	12	364 0.7×	143 0.3×	350 1.0×	101 0.6×	204 1.2×	34	869

Countries citing papers authored by Beiyang Wei

Since Specialization

Citations

This map shows the geographic impact of Beiyang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beiyang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beiyang Wei more than expected).

Fields of papers citing papers by Beiyang Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beiyang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beiyang Wei. The network helps show where Beiyang Wei may publish in the future.

Co-authorship network of co-authors of Beiyang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Beiyang Wei. A scholar is included among the top collaborators of Beiyang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beiyang Wei. Beiyang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Woodford, Mark R., Beiyang Wei, Mehdi Mollapour, et al.. (2018). Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine Kinase Controls MMP-2 Activity. iScience. 1. 87–96. 30 indexed citations

Wei, Beiyang, Yuji Yamada, Nadia P. Castro, et al.. (2017). Recombinant human Tissue Inhibitor of Metalloprotease −2; a novel anti‐cancer therapeutic. The FASEB Journal. 31(S1). 1 indexed citations

Brinson, Robert G., et al.. (2017). Tissue Inhibitor of Metalloprotease-2 (TIMP-2): Bioprocess Development, Physicochemical, Biochemical, and Biological Characterization of Highly Expressed Recombinant Protein. Biochemistry. 56(49). 6423–6433. 19 indexed citations

Jensen, Sandra, et al.. (2016). TIMP‐2 Deficiency Alters Host Immune Response in Murine Lung Tumor Microenvironment. The FASEB Journal. 30(S1). 1 indexed citations

Wei, Beiyang, et al.. (2015). Preclinical Development of Recombinant Human Tissue Inhibitor of Metalloprotease‐2 as a Novel Biologic Therapy for Cancer. The FASEB Journal. 29(S1). 2 indexed citations

Trombetta-Lima, Marina, Sheila Maria Brochado Winnischofer, Marcos Angelo Almeida Demasi, et al.. (2015). Isolation and characterization of novelRECKtumor suppressor gene splice variants. Oncotarget. 6(32). 33120–33133. 12 indexed citations

Bourboulia, Dimitra, Huiying Han, Sandra Jensen-Taubman, et al.. (2013). TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells. Oncotarget. 4(1). 163–173. 62 indexed citations

Guédez, Liliana, Sandra Jensen-Taubman, Dimitra Bourboulia, et al.. (2012). TIMP-2 Targets Tumor-associated Myeloid Suppressor Cells With Effects in Cancer Immune Dysfunction and Angiogenesis. Journal of Immunotherapy. 35(6). 502–512. 52 indexed citations

Bourboulia, Dimitra, et al.. (2011). Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment. American Journal Of Pathology. 179(5). 2589–2600. 56 indexed citations

10.

Tsang, Patricia, et al.. (2010). TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells. Laboratory Investigation. 90(3). 374–382. 29 indexed citations

11.

Seo, Dong Wan, Soo Hyeon Kim, Seok‐Hyun Eom, et al.. (2008). TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvascular Research. 76(3). 145–151. 44 indexed citations

12.

Poo, Haryoung, et al.. (2006). TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling. Biochemical and Biophysical Research Communications. 345(3). 1201–1206. 8 indexed citations

13.

Seo, Dong Wan, Hongmei Li, Junseo Oh, et al.. (2005). Shp-1 Mediates the Antiproliferative Activity of Tissue Inhibitor of Metalloproteinase-2 in Human Microvascular Endothelial Cells. Journal of Biological Chemistry. 281(6). 3711–3721. 121 indexed citations

14.

Oh, Junseo, Dong Wan Seo, Beiyang Wei, et al.. (2004). Tissue Inhibitors of Metalloproteinase 2 Inhibits Endothelial Cell Migration through Increased Expression of RECK. Cancer Research. 64(24). 9062–9069. 101 indexed citations

15.

Seo, Dong Wan, Hongmei Li, Liliana Guédez, et al.. (2003). TIMP-2 Mediated Inhibition of Angiogenesis. Cell. 114(2). 171–180. 425 indexed citations

16.

Matsumura, Martin E., et al.. (2001). Vascular Injury Induces Posttranscriptional Regulation of the Id3 Gene. Arteriosclerosis Thrombosis and Vascular Biology. 21(5). 752–758. 33 indexed citations

17.

Zhao, Min, et al.. (2000). Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8+ T cell recognition. Journal of Clinical Investigation. 106(6). R49–R58. 82 indexed citations

18.

Jung, Frank, A D Johnson, Beiyang Wei, et al.. (1999). Characterization of an E-box–Dependent cis Element in the Smooth Muscle α-Actin Promoter. Arteriosclerosis Thrombosis and Vascular Biology. 19(11). 2591–2599. 8 indexed citations

19.

Wei, Beiyang, et al.. (1992). Host dependence of naturally occurring temperature-sensitive influenza A viruses and location of their genetic lesions. Virus Research. 22(3). 207–214. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact